Viewing StudyNCT06102746



Ignite Creation Date: 2024-05-06 @ 7:42 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06102746
Status: RECRUITING
Last Update Posted: 2023-10-26
First Post: 2023-10-18

Brief Title: Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization: Tianjin Medical University Cancer Institute and Hospital

Conditions & Keywords Data

Conditions:
Name
Gastric Neuroendocrine Carcinoma
Keywords:
Name View
Surufatinib View
gastric neuroendocrine carcinoma View
Sintilimab View